These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 18092257

  • 1. Anticoagulant system activity in splenectomized versus non-splenectomized Iranian patients with beta-thalassemia major.
    Rashidi A, Alavi S, Arzanian MT, Ahmadinejad M.
    Pediatr Hematol Oncol; 2007 Dec; 24(8):645-7. PubMed ID: 18092257
    [No Abstract] [Full Text] [Related]

  • 2. Platelet aggregation and activation in thalassemia major patients in Indonesia.
    Setiabudy R, Wahidiyat PA, Setiawan L.
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):346-51. PubMed ID: 18160592
    [Abstract] [Full Text] [Related]

  • 3. [Oromaxillofacial changes in thalassemia major].
    De Mattia D, Pettini PL, Sabato V, Rubini G, Laforgia A, Schettini F.
    Minerva Pediatr; 1996 Jul; 48(1-2):11-20. PubMed ID: 9072660
    [Abstract] [Full Text] [Related]

  • 4. Thromboembolic complications in splenectomized patients with dominantly inherited beta-thalassemia.
    Ohga S, Ideguchi H, Kato J, Ishimura M, Takada H, Harada N, Kawanaka H, Hattori Y, Kang D, Hamasaki N, Hara T.
    Acta Haematol; 2008 Jul; 120(1):31-5. PubMed ID: 18728358
    [No Abstract] [Full Text] [Related]

  • 5. Hemostatic alterations in splenectomized and non-splenectomized patients with beta-thalassemia/hemoglobin E disease.
    Tripatara A, Jetsrisuparb A, Teeratakulpisarn J, Kuaha K.
    Thromb Res; 2007 Jul; 120(6):805-10. PubMed ID: 17382994
    [Abstract] [Full Text] [Related]

  • 6. Protein C and protein S deficiency in thalassemic patients.
    Shirahata A, Funahara Y, Opartkiattikul N, Fucharoen S, Laosombat V, Yamada K.
    Southeast Asian J Trop Med Public Health; 1992 Jul; 23 Suppl 2():65-73. PubMed ID: 1298996
    [Abstract] [Full Text] [Related]

  • 7. High transfusion in children with beta-thalassemia/Hb E: clinical and laboratory assessment of 18 cases.
    Torcharus K, Withayathawornwong W, Sriphaisal T, Krutvacho T, Arnutti P, Suwanasophorn C.
    Southeast Asian J Trop Med Public Health; 1993 Jul; 24 Suppl 1():96-9. PubMed ID: 7886617
    [Abstract] [Full Text] [Related]

  • 8. Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity.
    Gharagozloo M, Karimi M, Amirghofran Z.
    Ann Hematol; 2009 Jan; 88(1):21-7. PubMed ID: 18690440
    [Abstract] [Full Text] [Related]

  • 9. Hypercoagulable state in five thalassemia intermedia patients.
    Bhattacharyya M, Kannan M, Chaudhry VP, Mahapatra M, Pati H, Saxena R.
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):422-7. PubMed ID: 17911195
    [Abstract] [Full Text] [Related]

  • 10. Hypercoagulable state as demonstrated by thromboelastometry in hemoglobin E/beta-thalassemia patients: Association with clinical severity and splenectomy status.
    Natesirinilkul R, Charoenkwan P, Nawarawong W, Boonsri S, Tantivate P, Wongjaikum S, Manowong S, Sanguansermsri T.
    Thromb Res; 2016 Apr; 140():125-131. PubMed ID: 26971311
    [Abstract] [Full Text] [Related]

  • 11. Platelet Aggregation Study in Patients With Hemoglobin Eβ Thalassemia in India.
    Ghosal T, Dolai TK, Mandal PK, Karthik S, Bandyopadhyay A.
    Clin Appl Thromb Hemost; 2016 Sep; 22(6):575-80. PubMed ID: 25701765
    [Abstract] [Full Text] [Related]

  • 12. Impact of pretransplant splenectomy on patients with beta-thalassemia major undergoing a matched-related allogeneic stem cell transplantation.
    Mathews V, George B, Lakshmi KM, Viswabandya A, John JM, Sitaram U, Daniel D, Chandy M, Srivastava A.
    Pediatr Transplant; 2009 Mar; 13(2):171-6. PubMed ID: 18482210
    [Abstract] [Full Text] [Related]

  • 13. Thromboembolic complications in beta-thalassemia: Beyond the horizon.
    Panigrahi I, Agarwal S.
    Thromb Res; 2007 Mar; 120(6):783-9. PubMed ID: 17346783
    [Abstract] [Full Text] [Related]

  • 14. Pulmonary thromboembolism in thalassemic patients.
    Sonakul D, Fucharoen S.
    Southeast Asian J Trop Med Public Health; 1992 Mar; 23 Suppl 2():25-8. PubMed ID: 1298988
    [Abstract] [Full Text] [Related]

  • 15. Increased platelet adhesion under flow conditions is induced by both thalassemic platelets and red blood cells.
    Goldschmidt N, Spectre G, Brill A, Zelig O, Goldfarb A, Rachmilewitz E, Varon D.
    Thromb Haemost; 2008 Nov; 100(5):864-70. PubMed ID: 18989531
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Thrombotic complications in thalassemic patients: contribution of red blood cells and platelets.
    Shenkman B.
    Thromb Haemost; 2008 Nov; 100(5):735. PubMed ID: 18989511
    [No Abstract] [Full Text] [Related]

  • 20. Endocrinopathies in patients with transfusion-dependent beta-thalassemia.
    Mehrvar A, Azarkeivan A, Faranoush M, Mehrvar N, Saberinedjad J, Ghorbani R, Vossough P.
    Pediatr Hematol Oncol; 2008 Nov; 25(3):187-94. PubMed ID: 18432501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.